Marco Maccauro

3.3k total citations · 1 hit paper
81 papers, 1.9k citations indexed

About

Marco Maccauro is a scholar working on Oncology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Marco Maccauro has authored 81 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 29 papers in Epidemiology and 27 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Marco Maccauro's work include Neuroendocrine Tumor Research Advances (25 papers), Radiopharmaceutical Chemistry and Applications (21 papers) and Lung Cancer Research Studies (21 papers). Marco Maccauro is often cited by papers focused on Neuroendocrine Tumor Research Advances (25 papers), Radiopharmaceutical Chemistry and Applications (21 papers) and Lung Cancer Research Studies (21 papers). Marco Maccauro collaborates with scholars based in Italy, United States and Netherlands. Marco Maccauro's co-authors include Emilio Bombardieri, Claudio Chiesa, Vincenzo Mazzaferro, Ettore Seregni, Giordano Savelli, Carlo Spreafico, Alfonso Marchianò, Sherrie Bhoori, Rodolfo Lanocita and Raffaele Romito and has published in prestigious journals such as Blood, Hepatology and Cancer.

In The Last Decade

Marco Maccauro

78 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

2012 363 citations Vincenzo Mazzaferro, Sherrie Bhoori et al. profile →

Peers

Countries citing papers authored by Marco Maccauro

Since Specialization

Citations

This map shows the geographic impact of Marco Maccauro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Maccauro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Maccauro more than expected).

Fields of papers citing papers by Marco Maccauro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Maccauro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Maccauro. The network helps show where Marco Maccauro may publish in the future.

Co-authorship network of co-authors of Marco Maccauro

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Maccauro. A scholar is included among the top collaborators of Marco Maccauro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Maccauro. Marco Maccauro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Italian Association of Nuclear Medicine, Molecular Imaging and Therapy (AIMN) practical guide for peptide receptor radionuclide therapy (PRRT) with [177Lu]Lu-Oxodotreotide in gastroenteropancreatic neuroendocrine tumors (GEP-NET) 2025 ·Clinical and Translational Imaging ·Riccardo Laudicella, Domenico Albano, Matteo Bauckneht, Luca Urso, Lisa Bodei, Maria Luisa De Rimini, Chiara Maria Grana, Sergio Baldari, Annibale Versari, Angelina Filice, Mirco Bartolomei, Marco Maccauro	1
2	The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu]Lu-DOTATATE 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·Marco Maccauro, (unknown), Matteo Bauckneht, (unknown), (unknown), (unknown), (unknown), Margarita Kirienko, (unknown), G Aliberti, Sara Pusceddu, Giuseppina Calareso, (unknown), Ettore Seregni, Claudio Chiesa	11
3	Utility of pre-procedural [99mTc]TcMAA SPECT/CT Multicompartment Dosimetry for Treatment Planning of 90Y Glass microspheres in patients with Hepatocellular Carcinoma: comparison of anatomic versus [99mTc]TcMAA-based Segmentation 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·Marnix G. E. H. Lam, Étienne Garin, Paul Haste, Alban Denys, Brian Geller, S. Cheenu Kappadath, Cüneyt Türkmen, Daniel Y. Sze, (unknown), (unknown), Marco Maccauro, Murat Cantaşdemir, Matthew R. Dreher, Kirk Fowers, Vanessa L. Gates, Riad Salem	1
4	Cylindrical TGR as early radiological predictor of RLT progression in GEPNETs: a proof of concept 2024 ·Scientific Reports ·(unknown), (unknown), Giuseppina Calareso, Chiara Marzi, (unknown), (unknown), Michela Baccini, Sara Pusceddu, Alfonso Marchianò, Marco Maccauro	1
5	Lymphatic mapping and sentinel node biopsy in vulvar melanoma: the first multicenter study and systematic review 2023 ·Gynecologic Oncology ·Angela Collarino, (unknown), Giorgia Garganese, Tina Pasciuto, (unknown), (unknown), Simona Maria Fragomeni, (unknown), (unknown), Fabio Martinelli, Antonino Ditto, Ettore Seregni, Giovanni Scambia, Francesco Raspagliesi, Vittoria Rufini, Marco Maccauro	4
6	Bilateral inguinal lymph-node dissection vs. unilateral inguinal lymph-node dissection and dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penis 2023 ·Urologic Oncology Seminars and Original Investigations ·Sebastiano Nazzani, Mario Catanzaro, Davide Biasoni, Marco Maccauro, Silvia Stagni, Tullio Torelli, Alberto Macchi, Valentina Bernasconi, (unknown), (unknown), Alice Lorenzoni, Luigi Piva, Rodolfo Lanocita, Tommaso Cascella, Laura Cattaneo, E. Montanari, Roberto Salvioni, Nicola Nicolai	3
7	Radioembolization of Hepatocellular Carcinoma with 90Y Glass Microspheres: No Advantage of Voxel Dosimetry with Respect to Mean Dose in Dose–Response Analysis with Two Radiological Methods 2022 ·Cancers ·(unknown), (unknown), Marco Maccauro, Carlo Spreafico, (unknown), Gabriele Maffi, Carlo Morosi, Tommaso Cascella, Marta Mira-Aladrén, (unknown), G Aliberti, (unknown), (unknown), Sherrie Bhoori, (unknown), Alfonso Marchianò, Ettore Seregni, Vincenzo Mazzaferro, Claudio Chiesa	10
8	Dosimetric optimization of nuclear medicine therapy based on the Council Directive 2013/59/EURATOM and the Italian law N. 101/2020. Position paper and recommendations by the Italian National Associations of Medical Physics (AIFM) and Nuclear Medicine (AIMN) 2021 ·Physica Medica ·Claudio Chiesa, Lidia Strigari, Massimiliano Pacilio, (unknown), Vittorio Cannatà, M. Stasi, Maria Cristina Marzola, Orazio Schillaci, Oreste Bagni, Marco Maccauro	14
9	Update on radioligand therapy with ¹⁷⁷Lu-PSMA for metastatic castration-resistant prostate cancer: clinical aspects and survival effects 2021 ·Tumori Journal ·(unknown), (unknown), (unknown), Alice Lorenzoni, Valentina Guadalupi, (unknown), (unknown), G Aliberti, Claudio Chiesa, Giuseppe Procopio, Ettore Seregni, Marco Maccauro	4
10	1105P Predictive factors of adverse events onset in GEPNET patients treated with PRRT 2021 ·Annals of Oncology ·(unknown), (unknown), Alice Lorenzoni, Michela Baccini, (unknown), (unknown), Natalie Prinzi, Sara Pusceddu, Giuseppina Calareso, (unknown), Giovanni Centonze, Massimo Milione, Claudio Chiesa, Ettore Seregni, Marco Maccauro	0
11	Safety and activity of radium-223 in metastatic castration-resistant prostate cancer: the experience of Istituto Nazionale dei Tumori 2020 ·Tumori Journal ·Alessandra Raimondi, Pierangela Sepe, Mélanie Claps, Marco Maccauro, G Aliberti, Filippo Pagani, (unknown), Giovanni Randon, (unknown), Ettore Seregni, Elena Verzoni, Giuseppe Procopio	6
12	Radioembolization of hepatocarcinoma with 90Y glass microspheres: treatment optimization using the dose-toxicity relationship 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Claudio Chiesa, Marta Mira-Aladrén, Sherrie Bhoori, (unknown), Marco Maccauro, Carlo Spreafico, Tommaso Cascella, Anna Cavallo, (unknown), (unknown), Antonella Capozza, Giovanna Tagliabue, (unknown), Alfonso Marchianò, Ettore Seregni, Vincenzo Mazzaferro	42
13	Lymphoscintigraphy and sentinel lymph node biopsy in vulvar carcinoma: update from a European expert panel 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Angela Collarino, (unknown), Giorgia Garganese, Lenka M. Pereira Arias‐Bouda, Germano Perotti, Gianpiero Manca, Sergi Vidal‐Sicart, Francesco Giammarile, Lioe‐Fee de Geus‐Oei, Giovanni Scambia, Alessandro Giordano, R.A. Valdés-Olmos, Marco Maccauro	27
14	166Ho microsphere scout dose for more accurate radioembolization treatment planning 2019 ·European Journal of Nuclear Medicine and Molecular Imaging ·Claudio Chiesa, Marco Maccauro	18
15	Update on medical treatment of small intestinal neuroendocrine tumors 2016 ·Expert Review of Anticancer Therapy ·Sara Pusceddu, (unknown), Giuseppe Lo Russo, Silvia Ortolani, Massimo Milione, Marco Maccauro, Claudio Vernieri, Natalie Prinzi, Laura Concas, (unknown), Filippo de Braud, Roberto Buzzoni	4
16	Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: Results and clinical implications after eight-years follow-up 2014 ·The Breast ·Roberto Agresti, Flavio Crippa, Marco Sandri, Gabriele Martelli, Elda Tagliabue, Alessandra Alessi, (unknown), Marco Maccauro, Ilaria Maugeri, (unknown), (unknown), (unknown), Cristina Ferraris, Maria Luisa Carcangiu, Giulia Bianchi, Marco Greco, Emilio Bombardieri	1
17	MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role? 2008 ·PubMed ·Maria Rita Castellani, Ettore Seregni, Marco Maccauro, Claudio Chiesa, G Aliberti, (unknown), Emilio Bombardieri	34
18	Hysteroscopy in endometrial cancer: new methods to evaluate transtubal leakage of saline distension medium 2008 ·American Journal of Obstetrics and Gynecology ·Eugenio Solima, (unknown), Antonino Ditto, Shigeki Kusamura, Fabio Martinelli, Francesco Hanozet, Maria L. Carcangiu, Marco Maccauro, Francesco Raspagliesi	20
19	Incident pain and analgesic consumption decrease after samarium infusion: a pilot study 2006 ·Supportive Care in Cancer ·Carla Ripamonti, Elena Fagnoni, Tiziana Campa, Ettore Seregni, Marco Maccauro, Emilio Bombardieri	21
20	False-negative sentinel node in patients with vulvar cancer: A case study 2003 ·International Journal of Gynecological Cancer ·Francesco Raspagliesi, Antonino Ditto, Rosanna Fontanelli, Marco Maccauro, M.L. Carcangiu, Fabio Parazzini, Emilio Bombardieri	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact